Abstract
It is a common experience in cancer chemotherapy, as in practically every other field of therapeutics, that the response to treatment with antineoplastic agents quite frequently varies between individuals. Variability in therapeutic effectiveness can depend on the tumor itself and on the host; our knowledge of both these aspects is still quite limited, especially at the clinical level. In this paper we concentrate mainly on the host’s contribution to variability, using experimental models to study factors which, at different levels, may decisively influence the chemotherapeutic efficacy and toxicity of anticancer agents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brock, N., Hohorst, H.-J. : Metabolism of cyclophosphamide. Cancer (Philad.) 20, 900 (1967).
Connors, T. A., Grover, P. L., Mcloughlin, A. M.: Microsomal activation of cyclophosphamide in vivo. Biodiem. Pharmacol. 19, 1533 (1970).
Friedman, O. N., Boger, E.: Colorimetric estimation of nitrogen mustards in aqueous media. Hydrolytic behavior of bis(b -chloroethyl)amine, nor-HN2. Analyt. Chem. 33, 906 (1961).
Hill, D. L., Laster, W. R., JR., Struck, R. F.: Enzymic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. Cancer Res. 32, 658 (1972).
Jerne, N. K., Nordin, A. A.: Plaque formation in agar by single antibody-producing cells. Science 140, 405 (1963).
Morselli, P. L., Marc, V., Garattini, S., Zaccala, M.: Metabolism of exogenous Cortisol in humans. I. Diurnal variation in plasma disappearance rate. Biodiem. Pharmacol. 19, 1643 (1970 a).
Morselli, P. L., Marc, V., Garattini, S., Zaccala, M.: Metabolism of exogenous Cortisol in humans. Influence of phenobarbital treatment on plasma Cortisol disappearance rate. Rev. Europ. fitud. clin. biol. 15, 195 (1970 b).
Rall, D. P.: Pharmacologic aspects of selective chemotherapy of leukemia and Burkitt’s tumor. Combination chemotherapy, advertent and inadvertent. Cancer Res. 27 , 2650 (1967).
Sladek, N. E.: Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo. Cancer Res. 33, 1150 (1973).
Spreafico, F., Vecchi, A., Anaclerio, A., Mantovani, A.: Drug interactions in cytotoxic treatment. Manuscript in preparation (1973 a).
Spreafico, F., Mantovani, A., Anaclerio, A., Vecchi, A.: Negative interactions in chemical immunosuppression. In preparation (1973 b).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Spreafico, F., Donelli, M.G., Vecchi, A., Bossi, A., Garattini, S. (1974). Factors Modifying the Activity and Toxicity of Anticancer Agents. In: Mathé, G., Oldham, R.K. (eds) Complications of Cancer Chemotherapy. Recent Results in Cancer Research, vol 49. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80848-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-80848-7_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80850-0
Online ISBN: 978-3-642-80848-7
eBook Packages: Springer Book Archive